×
Embecta EBIT 2021-2025 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Embecta ebit from 2021 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Embecta EBIT 2021-2025 | EMBC
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Embecta ebit from 2021 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Danaher (DHR)
$139.4B
CVS Health (CVS)
$80.1B
Elevance Health (ELV)
$68.3B
Cencora (COR)
$57.1B
DiDi Global (DIDIY)
$27.2B
Labcorp Holdings (LH)
$20.7B
Natera (NTRA)
$19.6B
BioMerieux (BMXMF)
$16.9B
EUROFINS SCIENT (ERFSF)
$13.9B
CochLear (CHEOY)
$13.1B
Solventum (SOLV)
$12.8B
ICON (ICLR)
$11.9B
Revvity (RVTY)
$11.3B
Viatris (VTRS)
$10.9B
Medpace Holdings (MEDP)
$9.2B
Avantor (AVTR)
$9.1B
Sonic Healthcare (SKHHY)
$8.8B
HealthEquity (HQY)
$8.7B
Caris Life Sciences,�Inc (CAI)
$8B
Charles River Laboratories (CRL)
$7.7B
Amplifon S.p.A (AMFPF)
$5.4B
Bausch + Lomb (BLCO)
$5B
BrightSpring Health Services (BTSG)
$3.5B
Sotera Health (SHC)
$3.2B
Surgery Partners (SGRY)
$2.9B
Alignment Healthcare (ALHC)
$2.6B
Concentras Parent (CON)
$2.5B
Organon (OGN)
$2.5B
GeneDx Holdings (WGS)
$2.3B
Progyny (PGNY)
$2B